Author Interviews, Breast Cancer / 17.06.2014

Jack Cuzick PhD Centre for Cancer Prevention Wolfson Institute of Preventive Medicine Queen Mary University of London, London UKMedicalResearch.com Interview with: Jack Cuzick PhD Centre for Cancer Prevention Wolfson Institute of Preventive Medicine Queen Mary University of London, London UK Dr. Cuzick offers the manuscript below to put the results of the Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial in focus for MedicalResearch.com.

The Prevention of Breast Cancer

The first human evidence that drug treatment might reduce the incidence of breast cancer was reported in 19851, where it was found that use of tamoxifen in a trial of women with breast cancer to reduce recurrence of existing tumours also had a major impact on new tumours in the opposite breast, reducing them from 10 to 3. That observation has subsequently been confirmed in several other adjuvant trials and an overview of all such trials indicates that after an average of about 8 years of follow up, 5 years of tamoxifen reduced new contralateral tumours by 39%, with similar effects in years 0-5 and 5-10 in women with oestrogen receptor positive or unknown primary tumours2. These observations and positive results from animal studies3, led to the evaluation of 5 years of tamoxifen in women without breast cancer, but at high risk in 4 large trials. A recent overview4 indicates a 33% reduction in all breast cancer after a 10 years follow up, with a larger reduction in years 0-5 (48%), when treatment was given, and a continuing (22%) effect in years 5-10. Reductions were seen for oestrogen receptor positive invasive cancer (44%) and DCIS (28%), but no effect was seen for both oestrogen receptor negative invasive cancer, where in fact a non-significant 13% (P=0.4) increase was observed. Somewhat larger effects were seen for these other selective estrogen receptor modulators (SERMs) – raloxifene, lasofoxifene and arzoxifene – in trials of osteoporotic women, where the primary endpoint was fracture reduction4. A subsequent head-to-head trial of raloxifene vs tamoxifen, showed tamoxifen to be about 20% more effective, but raloxifene had fewer side effects5. Lasofoxifene not only showed benefits for breast cancer reduction but also reduced fracture rates and heart disease6, and this multi-dimensional set of benefits makes it an attractive candidate for prevention. (more…)
Author Interviews, Exercise - Fitness, JCEM, Menopause / 24.05.2014

Unab I. Khan, M.B.,B.S., M.S.            Assistant Professor of Pediatrics and Family & Social Medicine Division of Adolescent Medicine The Children’s Hospital at Montefiore The Pediatric Hospital for Albert Einstein College of Medicine Bronx, NY 10467MedicalResearch.com Interview with: Unab I. Khan, M.B.,B.S., M.S.   Assistant Professor of Pediatrics and Family & Social Medicine Division of Adolescent Medicine The Children’s Hospital at Montefiore The Pediatric Hospital for Albert Einstein College of Medicine Bronx, NY 10467 MedicalResearch: What are the main findings of the study? Dr. Khan: We wanted to find factors that lead to either an increase or decrease in risk of developing cardiovascular disease. We found that in middle aged overweight and obese women, who may not have any medical problems like diabetes, high blood pressure, high cholesterol, an increase in weight over time and the development of any of the conditions stated above, increased the risk of cardiovascular disease significantly. On the other hand, even moderate physical activity decreased the risk of heart disease, even in the presence of the above stated conditions. (more…)
Author Interviews, CHEST, Menopause, Obstructive Sleep Apnea / 20.04.2014

MedicalResearch.com Interview with: Rodrigo Pinto Pedrosa, MD, PhD Sleep and Heart Laboratory, Pronto Socorro Cardiológico de Pernambuco Pernambuclo, Brazil MedicalResearch.com: What are the main findings of the study? Dr. Pedrosa: Perimenopause is associated with increased cardiovascular risk. This study evaluated the association between obstructive sleep apnea (OSA) and arterial stiffness and hypertension in perimenopausal women. OSA (apnea-hypopnea index: ≥5 events/hour) and moderate/severe OSA (apnea-hypopnea index: ≥15 events/h) were diagnosed in 111 (40.1%) and 31 (11.1%) of women, respectively.  Women with moderate/severe obstructive sleep apnea  had a higher prevalence of hypertension, were prescribed more medications for hypertension, had higher awake blood pressure,  nocturnal blood pressure,  diastolic blood pressure, as well as higher arterial stiffness (pulse wave velocity: 11.5 [10.1 to 12.3] vs 9.5 [8.6 to 10.8] m/s, p<0.001) than women without obstructive sleep apnea, respectively. Oxygen desaturation index during the night was independently associated with 24h arterial blood pressure and with arterial stiffness. (more…)
Author Interviews, NIH / 15.03.2014

Peter F. Schnatz, D.O. Associate Chair & Residency Program Director The Reading Hospital Department of OB/GYN Reading, PA  19612-6052MedicalResearch.com Interview with: Peter F. Schnatz, D.O. Associate Chair & Residency Program Director The Reading Hospital Department of OB/GYN Reading, PA  19612-6052 MedicalResearch.com: What are the main findings of the study? Dr. Schnatz: In a subsample of 576 women from the parent WHI CaD (calcium plus vitamin D supplementation)  trial* , there was a significant (38%) increase in mean serum 25OHD3 concentrations after two years (95% CI 1.29-1.47, p< 0.001) for women randomized to CaD (24.3ng/mL vs. 18.2 ng/mL). Women randomized to CaD had a 4.5 mg/dL mean decrease in LDL-C which was statistically significant.  After accounting for serum 25OHD3 concentration, the effect of CaD was attenuated, suggesting that higher concentrations of 25OHD3, in response to CaD supplementation, are associated with improved LDL-C. In observational analyses, higher concentrations of 25OHD3 were associated with significantly higher HDL-C along with significantly lower LDL-C and TG concentrations. * 1,000 mg of elemental calcium plus 400 IU of vitamin D3 daily (more…)
Author Interviews, Blood Pressure - Hypertension, Exercise - Fitness, Menopause / 25.02.2014

MedicalResearch.com Interview with: Michael Nyberg Ph.D. Post-doc  Human Physiology and Exercise Physiology Integrated Physiology Group Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen and Jens Bangsbo, Dr. Sci., Ph.D. Professor of Human Physiology and Exercise Physiology Head of Integrated Physiology Group, Section of Human Physiology Head of Copenhagen Centre of Team Sports and Health Deputy Head of Department, research Copenhagen Denmark MedicalResearch.com: What are the main findings of the study? Answer: The main findings of the study were that despite being of similar age, the postmenopausal displayed higher blood pressure and higher blood levels of an early marker of atherosclerosis than women that had not reached menopause. Furthermore, just 12 weeks of floorball training twice a week for one hour improved the women’s conditions and reduced their blood pressure significantly. In addition, there was positive development in levels of substances vital to blood vessel function, including a decrease in the early marker of atherosclerosis. (more…)
Antioxidants, Author Interviews, Menopause, Sleep Disorders / 06.02.2014

MedicalResearch.com Interview with: Chih-Jen Chang, MD Department of Family Medicine National Cheng Kung University Hospital, Tainan, Taiwan MedicalResearch.com: What are the main findings of the study? Dr. Chang:  Postmenopausal women without vasomotor symptoms (hot flushes and night sweats) have poorer sleep quality than premenopausal women. In addition, menopause and snoring are associated with an increased risk of poor sleep quality independently of cardiometabolic factors and lifestyle. (more…)
Author Interviews, Mayo Clinic, Menopause, Sugar / 06.12.2013

Maki Inoue-Choi, PhD, MS, RD Division of Cancer Epidemiology and Genetics, National Cancer Institute National Institute on Minority Health and Health Disparities, NIH Rockville, MD 20850MedicalResearch.com Interview with: Maki Inoue-Choi, PhD, MS, RD Division of Cancer Epidemiology and Genetics, National Cancer Institute National Institute on Minority Health and Health Disparities, NIH Rockville, MD 20850 MedicalResearch.com: What are the main findings of the study? Answer: In our study, postmenopausal women who reported higher consumption of sugar-sweetened beverages were more likely to develop estrogen-dependent type I endometrial cancer, the most common type of this cancer. (more…)
Author Interviews, Menopause, University of Pennsylvania / 03.10.2013

MedicalResearch.com Interview with: Katherine Newton, PhD Senior Investigator at Group Health Research Institute in Seattle MedicalResearch.com: What are the main findings of the study? Answer: We found that when women took a 12-week yoga class and practiced yoga at home, they had significantly less insomnia than did women who did not. This was the only statistically significant finding in this MsFLASH (Menopause Strategies: Finding Lasting Answers for Symptoms and Health) Network randomized controlled trial. We also found that being in the yoga class did not decrease the number of hot flashes or night sweats. Yoga  was linked to better sleep quality and less depression—but  these effects were not statistically significant. In separate papers, published slightly earlier, our MsFLASH group reported that a non-yoga exercise program seemed linked to slightly improved sleep and less insomnia and depression—but these effects were not statistically significant. And an omega-3 (fish oil) supplement was not linked to any improvement in hot flashes, night sweats, sleep, or mood.   (more…)
Author Interviews, Exercise - Fitness, Menopause / 03.09.2013

MedicalResearch.com Interview with: Pascale Mauriège, PhD, Division of Kinesiology PEPS, Room 2148, Laval University, Québec, Canada G1K 7P4 MedicalResearch.com: What are the main findings of the study? Answer: 1)    The impact of a 4-month brisk walking program (3 sessions/week of 45-min walking at 60% of heart rate reserve) on postmenopausal moderately obese (BMI=29-35 kg/m2) women’s perceived health, and more particularly the perceived ideal weight and stress level. 2)    The existence of a relationship between improvements in perceived ideal weight and fat mass reduction in the walking group. 3)    The lack of non respondents to our novel self-administered Short Perceived Health Questionnaire (SPHQ) that was completed within 2-3 min by all participant. 4)    The good reproductibility for five of six items of the SHPQ, and the validation of three questions against generic tools. (more…)
Author Interviews, Menopause, Weight Research / 28.03.2013

MedicalResearch.com Interview with  Dr. Sylvia Santosa, PhD Department of Exercise Science Concordia University Department of Exercise Science Montreal, Quebec, Canada H4B 1R6Dr. Sylvia Santosa, PhD Department of Exercise Science Concordia University Department of Exercise Science Montreal, Quebec, Canada H4B 1R6 MedicalResearch.com: What are the main findings of the study? Dr. Santosa: Our results show that postmenopausal women burn less fat making more available to be stored.  Our results also suggest that greater fat storage in postmenopausal women are likely to be attributed to changes in the pathways our fat cells use to store fat.  We found that some of the proteins that help our fat cells store fat were more active and this greater activity corresponded with the amount of fat stored from our circulation. (more…)